Literature DB >> 9201704

The Wilms tumor protein is persistently associated with the nuclear matrix throughout the cell cycle.

Y Dobashi1, T Kudoh, T Ishidate, M Shoji, K Toyoshima, T Akiyama.   

Abstract

In order to investigate the subnuclear interactions of the WT1 gene product, nuclear fractionation analyses were performed with human osteosarcoma HOS and myelogenous leukemia K562 cells. The WT1 protein was tightly associated with the nucleus and was resistant to high-salt or detergent extraction and DNase I digestion. Both the expression level and stability of WT1 and its resistance to high salt and DNase I treatments remained constant during the cell cycle. In addition, human WT1 ectopically expressed in mouse NIH3T3 cells was also resistant to these treatments. These results suggest that WT1 functions in tight association with the nuclear matrix.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9201704     DOI: 10.1023/a:1006884527897

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  17 in total

1.  An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor.

Authors:  D A Haber; A J Buckler; T Glaser; K M Call; J Pelletier; R L Sohn; E C Douglass; D E Housman
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

2.  G1 phase arrest induced by Wilms tumor protein WT1 is abrogated by cyclin/CDK complexes.

Authors:  T Kudoh; T Ishidate; M Moriyama; K Toyoshima; T Akiyama
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

3.  WT-1 is required for early kidney development.

Authors:  J A Kreidberg; H Sariola; J M Loring; M Maeda; J Pelletier; D Housman; R Jaenisch
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

4.  Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus.

Authors:  K M Call; T Glaser; C Y Ito; A J Buckler; J Pelletier; D A Haber; E A Rose; A Kral; H Yeger; W H Lewis
Journal:  Cell       Date:  1990-02-09       Impact factor: 41.582

5.  Cloning of a human gene, PIG-F, a component of glycosylphosphatidylinositol anchor biosynthesis, by a novel expression cloning strategy.

Authors:  N Inoue; T Kinoshita; T Orii; J Takeda
Journal:  J Biol Chem       Date:  1993-04-05       Impact factor: 5.157

6.  Transcriptional repression mediated by the WT1 Wilms tumor gene product.

Authors:  S L Madden; D M Cook; J F Morris; A Gashler; V P Sukhatme; F J Rauscher
Journal:  Science       Date:  1991-09-27       Impact factor: 47.728

7.  Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1.

Authors:  I A Drummond; S L Madden; P Rohwer-Nutter; G I Bell; V P Sukhatme; F J Rauscher
Journal:  Science       Date:  1992-07-31       Impact factor: 47.728

8.  Nuclear binding of purified retinoblastoma gene product is determined by cell cycle-regulated phosphorylation.

Authors:  D J Templeton
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

9.  Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing.

Authors:  S H Larsson; J P Charlieu; K Miyagawa; D Engelkamp; M Rassoulzadegan; A Ross; F Cuzin; V van Heyningen; N D Hastie
Journal:  Cell       Date:  1995-05-05       Impact factor: 41.582

10.  Nuclear localization of the protein encoded by the Wilms' tumor gene WT1 in embryonic and adult tissues.

Authors:  S Mundlos; J Pelletier; A Darveau; M Bachmann; A Winterpacht; B Zabel
Journal:  Development       Date:  1993-12       Impact factor: 6.868

View more
  1 in total

1.  The Wilms' tumour suppressor protein WT1 acts as a key transcriptional repressor of the human thromboxane A2 receptor gene in megakaryocytes.

Authors:  AnneMarie M Gannon; B Therese Kinsella
Journal:  J Cell Mol Med       Date:  2009 Nov-Dec       Impact factor: 5.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.